<DOC>
	<DOCNO>NCT00870467</DOCNO>
	<brief_summary>To evaluate potential adalimumab inhibit radiographic progression joint destruction compare placebo adult Japanese subject recent onset rheumatoid arthritis .</brief_summary>
	<brief_title>A Study Adalimumab Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description>This Phase 3 multicenter , randomize , double-blind , parallel group , placebo-controlled study design evaluate inhibition radiographic progression adalimumab compare placebo adult Japanese patient early rheumatoid arthritis ( RA ) previously treat methotrexate ( MTX ) . Eligible participant randomize 1:1 receive either subcutaneous injection adalimumab 40 mg match placebo every week ( eow ) 26-week double-blind phase . All participant also receive 6 mg 8 mg MTX weekly basal treatment disease . Participants experience increase disease activity ( 20 % increase tender joint count swell joint count ) Week 12 , 16 , 20 compare Baseline increase MTX dose 8 mg per week least 4 week discontinue double-blind phase eligible receive open-label adalimumab 40 mg eow rescue treatment . Participants complete 26 week treatment ( either double-blind study drug [ adalimumab placebo ] treatment open-label adalimumab treatment ) eligible enter 26-week open-label phase receive adalimumab 40 mg eow . Efficacy safety assessment perform Baseline designate study visit .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Inclusion Criteria Rheumatoid arthritis base American College Rheumatology criterion Methotrexate leflunomide na√Øve Disease duration less equal 2 year diagnosis Exclusion Criteria History acute inflammatory joint disease different origin rheumatoid arthritis , cancer , lymphoma , leukemia lymphoproliferative disease , active TB , HIV Previously receive antiTNF therapy antiIL6 receptor antibody , CTLA4Ig , antiCD20 antibody , cyclophosphamide , cyclosporine , azathioprine , tacrolimus Joint surgery involve joint assess within 8 week prior Screening</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>